Orexigen asks FDA for weight-loss drug approval BusinessWeek Orexigen Therapeutics Inc. said Wednesday it has filed for Food and Drug Administration approval of its potential weight-loss drug Contrave. ... Orexigen(R) Therapeutics Submits Contrave(R) New Drug Application to FDA for ... |
Wednesday, March 31, 2010
Orexigen asks FDA for weight-loss drug approval - BusinessWeek
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment